PRIMEX BIOCHEMICALS AS

5525 HAUGESUND

Finances

Return on Equity

−19,65 %

Current Ratio

3,58

Debt-to-Equity Ratio

0,62

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 675 000	2 808 000	3 050 000	3 473 000
Net Income	−367 000	653 000	−218 000	−1 137 000
Total Assets	3 990 000	4 913 000	4 286 000	4 044 000
Total Equity	1 868 000	2 235 000	1 582 000	1 800 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 675 000	2 808 000	3 050 000	3 473 000
Expenditure	1 955 000	2 087 000	3 186 000	4 398 000
Operating Profit	−280 000	720 000	−136 000	−926 000
Financial Income	14 000	19 000	22 000	22 000
Financial Costs	101 000	105 000	104 000	230 000
Financial Balance	−87 000	−86 000	−82 000	−208 000
Earnings Before Tax	−367 000	635 000	−218 000	−1 134 000
Tax	0	−18 000	0	3 000
Net Income	−367 000	653 000	−218 000	−1 137 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	557 000	583 000	613 000	483 000
Total Current Assets	3 433 000	4 330 000	3 673 000	3 561 000
Total Assets	3 990 000	4 913 000	4 286 000	4 044 000
Total Retained Equity	698 000	1 065 000	412 000	629 000
Total Equity	1 868 000	2 235 000	1 582 000	1 800 000
Total Long-Term Debt	1 163 000	1 284 000	1 403 000	850 000
Total Current Debt	959 000	1 394 000	1 301 000	1 394 000
Total Equity and Debt	3 990 000	4 913 000	4 286 000	4 044 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 508 000	2 354 000	3 050 000	3 473 000
Other Income	168 000	454 000	0	0
Revenue	1 675 000	2 808 000	3 050 000	3 473 000
Cost of Goods Sold	1 191 000	468 000	1 537 000	1 921 000
Salary Costs	271 000	713 000	831 000	1 160 000
Depreciation	26 000	29 000	10 000	8 000
Impairment	0	0	0	0
Expenditure	1 955 000	2 087 000	3 186 000	4 398 000
Operating Profit	−280 000	720 000	−136 000	−926 000
Financial Income	14 000	19 000	22 000	22 000
Financial Costs	101 000	105 000	104 000	230 000
Financial Balance	−87 000	−86 000	−82 000	−208 000
Dividends	0	0	0	0
Net Income	−367 000	653 000	−218 000	−1 137 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	78 000	104 000	130 000	0
Real Eastate	343 000	343 000	343 000	343 000
Machinery and Plant Facilities	0	0	3 000	0
Fixtures	0	0	0	11 000
Total Tangible Assets	343 000	343 000	346 000	354 000
Total Fiancial Fixed Assets	137 000	137 000	137 000	129 000
Total Fixed Assets	557 000	583 000	613 000	483 000
Stock	437 000	947 000	736 000	1 226 000
Total Investments	0	0	0	0
Cash, Bank	125 000	93 000	30 000	76 000
Total Current Assets	3 433 000	4 330 000	3 673 000	3 561 000
Total Assets	3 990 000	4 913 000	4 286 000	4 044 000
Total Equity	1 868 000	2 235 000	1 582 000	1 800 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 163 000	1 284 000	1 403 000	850 000
Creditors	146 000	336 000	634 000	565 000
Unpaid Taxes	311 000	63 000	37 000	114 000
Dividends	0	0	0	0
Other Current Debt	502 000	524 000	393 000	417 000
Total Current Debt	959 000	1 394 000	1 301 000	1 394 000
Total Equity and Debt	3 990 000	4 913 000	4 286 000	4 044 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−19,65 %	29,22 %	−13,78 %	−63,17 %
Debt-to-Equity Ratio	0,62	0,57	0,89	0,47
Operating Profit Margin	−16,72 %	25,64 %	−4,46 %	−26,66 %
Current Ratio	3,58	3,11	2,82	2,55
Quick Ratio	6,58	9,69	6,5	21,2
Equity Ratio	0,47	0,45	0,37	0,45
Gross Profit Margin	28,9 %	83,33 %	49,61 %	44,69 %